Safety and efficacy of sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes fasting during Ramadan: A meta-analysis
SGLT2i may be generally safe and effectively manage T2D during Ramadan; however, the results are less robust and should be interpreted with caution. Large multicenter randomized trials are necessary to confirm their safety, especially for at-risk groups, and to improve clinical decision-making.
Authors
- Hamid Ashraf (ORCID: https://orcid.org/0000-0001-8002-9142)
- Joseph M Pappachan (ORCID: https://orcid.org/0000-0003-0886-5255)
- Deep Dutta
- Abul Bashar Mohammad Kamrul-Hasan
- Lakshmi Nagendra
- Mohammad Shafi Kuchay
- Shehla Shaikh
Institutions
- Manchester Metropolitan University (GB)
- JSS Academy of Higher Education and Research (IN)
- University of Liverpool (GB)
- Manipal Academy of Higher Education (IN)
- Aligarh Muslim University (IN)
- Sir H.N. Reliance Foundation Hospital and Research Centre (IN)
- Max Super Speciality Hospital (IN)
- Countess of Chester Hospital NHS Foundation Trust (GB)
- Medanta The Medicity (IN)
- Countess of Chester Hospital (GB)
- Mymensingh Medical College Hospital (BD)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2026-02-06
- DOI
- https://doi.org/10.4239/wjd.v17.i2.115495
- Primary Topic
- Dietary Effects on Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Diabetes Association